Belotero Korean Version — CPM HA Filler for Natural Facial Rejuvenation
Belotero Korean Version is the Korean-channel distribution of Merz Pharma’s CPM (Cohesive Polydensified Matrix) HA filler — 22.5 mg/g cross-linked HA + 0.3% lidocaine. The CPM gradient-density gel structure mimics natural tissue, allowing seamless integration with surrounding dermis. Belotero is the #1 selling filler in Europe with over 10 million treatments globally.
Manufacturer: Merz Pharma (Korean Distribution), Switzerland (Korean Channel) · Established 2007
How Belotero Korean Version with Lidocaine Is Engineered
CPM (Cohesive Polydensified Matrix) Technology
Merz Pharma (Korean Distribution)’s proprietary cross-linking process produces a stabilised HA gel matrix engineered for sustained tissue retention. The technology balances viscoelasticity (firmness for projection) with extrusion smoothness (easier injection through the 27G 1/2″ needle). The result: predictable handling, consistent gel distribution, and 12-18 months durability in mid to deep dermis placement.
Quality & Purity
Non-animal hyaluronic acid produced by bacterial fermentation. Endotoxin levels controlled below international safety thresholds. Stringent manufacturing under GMP-certified conditions minimises BDDE residue, heavy metals, and protein contaminants — reducing the risk of post-injection inflammation, granuloma formation, or hypersensitivity reactions in suitable patient profiles.
Belotero Korean Version with Lidocaine Active Ingredients
Cross-Linked Hyaluronic Acid
Non-animal hyaluronic acid produced by bacterial fermentation, cross-linked using Merz Pharma (Korean Distribution)’s CPM (Cohesive Polydensified Matrix) Technology technology. The cross-linking process creates a stable, durable gel matrix that resists rapid enzymatic breakdown in tissue. Phosphate-buffered saline carries the gel at near-physiological pH.
Lidocaine HCl
Premixed local anaesthetic at the industry-standard 0.3% concentration. Reduces injection-site discomfort and eliminates the need for on-site mixing with separate lidocaine vials. The lidocaine itself wears off within hours of injection and does not affect long-term gel duration.
Where Belotero Korean Version with Lidocaine Is Used
Nasolabial Folds
Primary FDA-approved indication (as Belotero Balance). Mid-to-deep dermal placement for moderate-to-severe nose-to-mouth lines.
Marionette Lines
Oral commissure-to-jaw furrows. The CPM gradient density preserves natural facial movement.
Lip Contour
Vermillion border refinement and subtle lip body enhancement.
Tear Trough (Off-Label)
Subtle under-eye correction. The CPM technology minimises Tyndall effect in superficial placement.
Belotero Korean Version with Lidocaine vs Juvederm vs Restylane
| Feature | Belotero | Juvederm (Allergan) | Restylane (Galderma) |
|---|---|---|---|
| HA Concentration | 22.5 mg/g | 15–24 mg/mL | 20 mg/mL |
| Cross-Linking Tech | CPM | Vycross / Hylacross | NASHA® / OBT |
| Lidocaine | 0.3% (premixed) | 0.3% (XC lines) | 0.3% (Lidocaine variants) |
| Duration | 12-18 months | 6–24 months (varies) | 6–18 months (varies) |
| Origin | Switzerland (Korean Channel) (Merz Pharma (Korean Distribution)) | USA (Allergan / AbbVie) | Sweden (Galderma) |
| Established Since | 2007 | 2006 | 1996 |
↔ Swipe horizontally on mobile to view all columns
Comparison based on manufacturer published data. See our top dermal filler comparison guide for broader market context.
Belotero Korean Version with Lidocaine Product Specifications
Manufacturer
- Brand: Belotero
- Company: Merz Pharma (Korean Distribution)
- Country: Switzerland (Korean Channel)
- Established: 2007
Formula
- HA Source: Non-animal bacterial fermentation
- HA Concentration: 22.5 mg/g
- Lidocaine: 0.3% (3 mg/mL) premixed
- Cross-linking: CPM (Cohesive Polydensified Matrix) Technology
Performance
- Duration: 12-18 months
- Injection Depth: Mid to deep dermis
- Recommended Needle: 27G 1/2″
- Last Reviewed: May 2026
Approval & Storage
- Approvals: FDA approved (Belotero Balance) · CE marked · Merz registered
- Packaging: 1 x 1 mL pre-filled syringe + 27G 1/2″ needles
- Storage: 2–25 °C, do not freeze
- Shelf life: 24 months unopened
Verify regulatory status at the official Korean MFDS database — nedrug.mfds.go.kr. For market pricing context, see our dermal filler pricing guide.
Belotero Korean Version with Lidocaine — Frequently Asked Questions
What is Belotero Korean Version with Lidocaine?
Belotero Korean Version is the Korean-channel distribution of Merz Pharma’s CPM (Cohesive Polydensified Matrix) HA filler — 22.5 mg/g cross-linked HA + 0.3% lidocaine. The CPM gradient-density gel structure mimics natural tissue, allowing seamless integration with surrounding dermis. Belotero is the #1 selling filler in Europe with over 10 million treatments globally.
Where is Belotero Korean Version with Lidocaine manufactured?
Belotero Korean Version with Lidocaine is manufactured by Merz Pharma (Korean Distribution), a Switzerland (Korean Channel)-based medical device and pharmaceutical company established in 2007. The product is part of the Belotero dermal filler range, which is distributed across multiple international markets. Regulatory status: FDA approved (Belotero Balance) · CE marked · Merz registered.
What is the HA concentration in Belotero Korean Version with Lidocaine?
Belotero Korean Version with Lidocaine contains 22.5 mg/g of cross-linked hyaluronic acid plus 0.3% (3 mg/mL) premixed lidocaine for injection comfort. The hyaluronic acid is non-animal, produced by bacterial fermentation and cross-linked using Merz Pharma (Korean Distribution)’s CPM (Cohesive Polydensified Matrix) Technology technology. Phosphate-buffered saline at near-physiological pH carries the gel.
How long do Belotero Korean Version with Lidocaine results last?
Per Merz Pharma (Korean Distribution)’s clinical data, Belotero Korean Version with Lidocaine delivers 12-18 months of correction depending on placement and patient factors. Duration depends on injection depth, dose, anatomical site, patient metabolism, and facial movement intensity. Mid to deep dermis placement typically delivers the longer end of the duration range.
What is the recommended injection depth for Belotero Korean Version with Lidocaine?
Belotero Korean Version with Lidocaine is engineered for mid to deep dermis placement. The standard recommended needle is 27G 1/2″, supplied in the syringe blister pack. Some practitioners prefer a blunt-tip cannula of equivalent gauge for safer placement in highly vascular zones, particularly for deeper subcutaneous work.
Is Belotero Korean Version with Lidocaine FDA approved or CE marked?
Belotero Korean Version with Lidocaine regulatory status: FDA approved (Belotero Balance) · CE marked · Merz registered. The product’s KFDA registration in South Korea is the primary regulatory baseline. CE marking and other international approvals enable distribution in the EU and other regulated markets. US FDA status varies — buyers in regulated jurisdictions should verify approval scope before importation and clinical use.
How should Belotero Korean Version with Lidocaine be stored at the clinic?
Store Belotero Korean Version with Lidocaine between 2 °C and 25 °C in original packaging, away from direct sunlight. Do not freeze — freezing damages the HA gel structure. Shelf life is typically 24 months from the manufacturing date printed on the box when unopened. Once a syringe is opened, contents must be used immediately. Partial syringes cannot be retained for later use due to sterility risk.
Does Belotero Korean Version with Lidocaine contain animal-derived ingredients?
No. Belotero Korean Version with Lidocaine uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products. The product is contraindicated in patients with severe allergies to gram-positive bacterial proteins (used in HA fermentation).
Can Belotero Korean Version with Lidocaine be combined with other dermal fillers in the same session?
Yes — layered protocols combining different fillers are standard aesthetic practice. Belotero Korean Version with Lidocaine can be combined with other Korean or international HA fillers, neuromodulators (botulinum toxin), or biostimulators (PLLA, calcium hydroxylapatite) within a single session. Always wait the recommended interval between different injectable products and confirm biocompatibility per each manufacturer’s IFU.
What is CPM technology in Belotero fillers?
CPM (Cohesive Polydensified Matrix) is Merz Pharma’s proprietary HA cross-linking process producing a gradient-density gel — combining high-density and low-density HA areas within a single product. This gradient structure allows the gel to mimic natural tissue behaviour: integrating seamlessly with surrounding dermis while preserving normal facial movement. The result: a filler that blends with skin so well that it virtually disappears under palpation while maintaining structural integrity for natural, long-lasting outcomes. CPM is the foundational technology across the entire Belotero range (Soft, Balance, Intense, Volume).
Other HA Dermal Fillers on Fillersfairy
Juvederm Ultra 2 with Lidocaine (2 x 0.55ml)
Juvederm Ultra 2 is Allergan’s lightest Hylacross-technology filler — 24 mg/mL cross-linked non-animal hyaluronic acid + 0.3% l…
View product →Juvederm Ultra 3 with Lidocaine (2 x 1ml)
Juvederm Ultra 3 is Allergan’s medium-density Hylacross filler — 24 mg/mL cross-linked HA + 0.3% lidocaine produced by Streptoc…
View product →Juvederm Ultra 4 with Lidocaine (2 x 1ml)
Juvederm Ultra 4 is Allergan’s deepest Hylacross-series filler — 24 mg/mL cross-linked HA + 0.3% lidocaine engineered for deep …
View product →All Dermal Fillers
Browse our full range of HA dermal fillers, lip fillers, body fillers, and skin boosters for facial volume, contouring, and rejuvenation.
Browse category →Read Before Clinical Use
Belotero Korean Version with Lidocaine is a prescription medical device for use only by licensed aesthetic practitioners. Common reactions include injection-site bruising, swelling, redness, and tenderness — generally resolving within days. Like all hyaluronic acid dermal fillers, treatment carries rare but serious vascular complication risks. Contraindicated in patients with known hypersensitivity to hyaluronic acid or lidocaine, active skin infection at the treatment site, pregnancy, or breastfeeding. Full contraindications, vascular complication protocols, aftercare, and emergency guidance are detailed on the dermal filler safety page.
Read Full Dermal Filler Safety Information →Belotero is a registered trademark of Merz Pharma (Korean Distribution). Fillersfairy.com is a channel distributor and does not provide medical advice. This page is for informational purposes only and does not replace the manufacturer’s official Instructions for Use, which remains the authoritative source for clinical administration. Regulatory status varies by jurisdiction — buyers are responsible for verifying legal status before ordering. Last reviewed May 2026 against Merz Pharma (Korean Distribution) manufacturer documentation.


Reviews
There are no reviews yet.